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Abstract. 
 
Mitosis is controlled by the speciﬁc and
timely degradation of key regulatory proteins, notably
 
the mitotic cyclins that bind and activate the cyclin-
dependent kinases (Cdks). In animal cells, cyclin A is al-
ways degraded before cyclin B, but the exact timing and
the mechanism underlying this are not known. Here we
use live cell imaging to show that cyclin A begins to be
degraded just after nuclear envelope breakdown. This
degradation requires the 26S proteasome, but is not af-
fected by the spindle checkpoint. Neither deletion of its
destruction box nor disrupting Cdk binding prevents
cyclin A proteolysis, but Cdk binding is necessary for
degradation at the correct time. We also show that in-
creasing the levels of cyclin A delays chromosome
alignment and sister chromatid segregation. This delay
depends on the proteolysis of cyclin A and is not caused
 
by a lag in the bipolar attachment of chromosomes to the
mitotic spindle, nor is it mediated via the spindle check-
point. Thus, proteolysis that is not under the control of
the spindle checkpoint is required for chromosome
alignment and anaphase.
Key words: cyclin • proteolysis • chromosome • mito-
sis • cell cycle
 
Introduction
 
In animal cells, the mitotic cyclins A and B are required
for entry into mitosis. But, equally as important, their re-
moval is essential for exit from mitosis (for review see
Norbury and Nurse, 1993). A nondegradable version of
cyclin B arrests cells at the end of anaphase (Holloway et
al., 1993; Wheatley et al., 1997), but it is unclear how cells
respond to nondegradable cyclin A: cleaving 
 
Xenopus
 
 em-
bryos arrest with condensed chromosomes (Luca et al.,
1991) and 
 
Drosophila 
 
cells exhibit a delay, rather than a
permanent arrest, in metaphase (Sigrist et al., 1995).
The central role of ubiquitin-mediated degradation in the
regulation of mitosis is firmly established (for review see
King et al., 1996a). Ubiquitin-mediated degradation entails
the covalent attachment of ubiquitin to target proteins by
an ubiquitin carrier protein (E2) and usually an ubiquitin li-
gase (E3) (Hershko and Ciechanover, 1998). In mitosis, the
major E3 complex is the anaphase-promoting complex
 
(APC)
 
1
 
/cyclosome (King et al., 1995; Sudakin et al., 1995).
The APC is under complex control via phosphorylation and
by binding one of two WD 40 repeat proteins: Cdc20 and
Cdh1/Hct1 in yeast, Fizzy and Fizzy-related in 
 
Drosophila
 
,
or p55cdc/hCdc20 and hCdh1 in humans (for review see
Morgan, 1999). In early mitosis the APC binds Cdc20 and
recognizes proteins containing a 9–amino acid RxxLxxxxN
motif called the “destruction box” (D-box) (Glotzer et al.,
1991; Yamano et al., 1998). This motif is required for the
degradation of both cyclin B1 and the anaphase inhibitor,
securin, in metaphase (for review see Yamano et al., 1998).
The APC is regulated by the spindle checkpoint, which
delays anaphase should any chromosome not attach to
both poles of the spindle (Rieder et al., 1994, 1995; Li and
Nicklas, 1995). The checkpoint acts via a signal transduc-
tion pathway composed of the Mad and Bub proteins to
inactivate Cdc20 (Hardwick, 1998; for review see Taylor,
1999). This prevents the degradation of securin and conse-
quent chromosome segregation until all the chromosomes
are attached to both spindle poles (Yamamoto et al., 1996;
Alexandru et al., 1999).
Both cyclins A and B1 are degraded in mitosis by ubiq-
uitin-mediated proteolysis (Glotzer et al., 1991; Hershko
et al., 1994; King et al., 1995; Sudakin et al., 1995) and their
degradation pathways share common components. The
APC can ubiquitylate cyclins A and B1 in vitro (Sudakin et
al., 1995) and a dominant negative mutant of the human E2,
Ubc10, arrests cells in mitosis with high levels of cyclins A
and B1 (Townsley et al., 1997; Bastians et al., 1999). Both cy-
 
clin A and B1 have an NH
 
2
 
-terminal D-box that is required
 
for their degradation in 
 
Xenopus
 
 oocyte extracts (Glotzer et
al., 1991; Kobayashi et al., 1992; Lorca et al., 1992a; King et
al., 1996b). A functional D-box is also required for the mi-
totic degradation of human cyclin B1 in vivo (Clute and
 
J
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Abbreviations used in this paper: 
 
APC, anaphase-promoting complex;
CAK, Cdk–activating kinase; Cdk, cyclin-dependent kinase; CFP, cyan fluo-
rescent protein; D-box, destruction box; DIC, differential interference con-
trast; GFP, green fluorescent protein; GST, glutathione 
 
S
 
-transferase;
NEBD, nuclear envelope breakdown; YFP, yellow fluorescent protein. 
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Pines, 1999). The D-box has not been shown directly to be re-
quired for the degradation of human cyclin A, but deleting
the first 70 amino acids, including the D-box, prevents its deg-
radation in human G1 phase extracts (Bastians et al., 1999).
However, substituting the D-box of 
 
Xenopus
 
 cyclin B1 with
that of 
 
Xenopus
 
 cyclin A renders cyclin B1 nondegradable in
 
Xenopus
 
 extracts, whereas the D-box of cyclin B1 supports
the proteolysis of cyclin A (King et al., 1996b; Klotzbucher et
al., 1996). In addition, the degradation in vitro of 
 
Xenopus
 
 cy-
clin B1 does not require it to bind its cyclin-dependent kinase
(Cdk) partner, but this is required for the degradation of 
 
Xe-
nopus
 
 cyclin A (Stewart et al., 1994).
The differences between cyclin A and B degradation
may be relevant to the observation that activating the
spindle checkpoint by disrupting the spindle with nocoda-
zole or colchicine inhibits the degradation of cyclin B, but
not cyclin A (Pines and Hunter, 1990; Whitfield et al.,
1990; Hunt et al., 1992; Bastians et al., 1999). However, in
apparent contradiction to this, a mutation in 
 
fizzy
 
, a down-
stream target of the spindle checkpoint, prevents the deg-
radation of both 
 
Drosophila 
 
cyclins A and B (Dawson et
al., 1995; Sigrist et al., 1995). Similarly, adding anti-Fizzy
antibodies to 
 
Xenopus
 
 egg extracts stabilizes both A and B
type cyclins (Lorca et al., 1998).
To understand how cyclin A is degraded and how ubiq-
uitin-mediated degradation is regulated during mitosis, the
timing of cyclin A degradation must first be determined.
In all systems studied thus far cyclin A is always degraded
before cyclin B1 (Luca and Ruderman, 1989; Lehner and
O’Farrell, 1990; Minshull et al., 1990; Pines and Hunter,
1990, 1991; Whitfield et al., 1990; Hunt et al., 1992). Hu-
man cyclin B1 begins to be degraded at the beginning of
metaphase (Clute and Pines, 1999), consistent with its in-
hibition by the spindle checkpoint. However, the precise
timing of cyclin A degradation is still unclear. From immu-
nofluorescence studies, it has been reported that human
cyclin A protein levels decrease at any time from pro-
metaphase to late anaphase (Pines and Hunter, 1991; Pa-
gano et al., 1992; Girard et al., 1995).
We have used green fluorescent protein (GFP)-linked
cyclin A, together with time-lapse fluorescence and differ-
ential interference contrast (DIC) microscopy, to analyze
the dynamics of cyclin A degradation in mammalian cells
in real time. Our results indicate that cyclin A is degraded
via a D-box–independent mechanism once the nuclear en-
velope has broken down (NEBD) and implicate ubiquitin-
mediated degradation in chromosome alignment.
 
Materials and Methods
 
Cell Culture and Synchronization
 
HeLa cells and PtK
 
1
 
 cells were cultured and synchronized as described
previously (Clute and Pines, 1999).
 
Construction of cDNA Plasmids
 
All cyclin A fusion proteins and mutations were constructed by PCR using
Vent polymerase (New England Biolabs, Inc.), cloned into appropriate vec-
tors, and confirmed by automated sequencing. Myc-tagged 
 
Hs
 
 cyclin
A–GFP (Furuno et al., 1999) was cloned into pcDNA3 (Invitrogen). Myc-
tagged cyclin A was linked via an AGAEF linker to a cyan fluorescent pro-
tein (CFP; CLONTECH Laboratories, Inc.) to give pcDNA3-myc-cyclin
A–CFP. All other cDNA constructs containing point mutations and dele-
tions of cyclin A were fused to MmGFP via an AGAEF linker. The cyclin A
D-box (RAALAVLKS) was replaced with that of cyclin B1 (RTALG-
DIGN) to give pcDNA3-myc-B1 D-box-cyclin A–GFP; R
 
47
 
 of cyclin A was
 
replaced with an alanine to give pcDNA3-myc-R47A cyclin A–GFP; the
D-box of cyclin A was deleted (RT
 
46
 
-G
 
56
 
NP-) for pcDNA3-myc-
 
D
 
D-box
cyclin A–GFP; R
 
211
 
 was replaced with an alanine to give pcDNA3-myc-
MAAIL cyclin A–GFP; the NH
 
2
 
-terminal 97 amino acids of cyclin A were
replaced with a methionine residue to give 
 
D
 
N97 cyclin A–GFP; and the
amino acids COOH-terminal to A
 
98
 
 of cyclin A and 
 
D
 
D-box cyclin A were
removed to give pcDNA3-myc-1–98 cyclin A–GFP and pcDNA3-myc-1–98
 
D
 
D-box cyclin A–GFP, respectively. pCMX-cyclin B1–yellow fluorescent
protein (YFP) has been described previously (Hagting et al., 1999). pEF-
Bub1-dominant negative was provided by Stephan Geley and Tim Hunt
(Imperial Cancer Research Fund, London, UK). All plasmid preparations
were resuspended in 10 mM Tris, pH 8.0, for microinjection.
Baculovirus expression constructs of cyclin A and (His)
 
6
 
-Cdk2 have been
described previously (Krude et al., 1997). Both MmGFP alone and the 
 
D
 
N97
cyclin A–GFP construct were cloned downstream of glutathione 
 
S
 
-trans-
ferase (GST) in pGEX-2T (Amersham Pharmacia Biotech). A GST-Cdk–
activating kinase (CAK) construct was provided by Carl Mann (Commissar-
iat à L’Energie Atomique [CEA], Saclay, France). An expression construct
for GroEL and GroES was provided by Dr. George Banting (University of
Bristol, Bristol, UK). Maps of all constructs are available on request.
 
Protein Expression and Purification and Histone H1 
Kinase Assays
 
Cyclin A–(His)
 
6
 
-Cdk2 and cyclin A-GFP–(His)
 
6
 
-Cdk2 complexes and
(His)
 
6
 
-cyclin A–GFP and (His)
 
6
 
-Cdk2 proteins were expressed in baculovi-
rus-infected Sf9 cells and purified as described previously (Krude et al.,
1997). Proteins were concentrated in 10 mM Hepes, pH 7.4, 150 mM NaCl,
1 mM EDTA using Vivaspin microconcentrators and stored as 10% glyc-
erol stocks. GST-GFP, GST-
 
D
 
N97 cyclin A–GFP, and GST-CAK proteins
were expressed in 
 
Escherichia coli 
 
BL21 and purified as described previ-
ously (Hagting et al., 1999). GST-
 
D
 
N97 cyclin A–GFP was coexpressed with
GroEL and GroES. GFP and 
 
D
 
N97 cyclin A–GFP were cleaved from GST
with thrombin (Sigma-Aldrich) or Factor Xa (Novagen), respectively, and
GST-CAK was eluted from glutathione-Sepharose (Amersham Pharmacia
Biotech) according to the manufacturer’s instructions. Factor Xa was re-
moved from GFP protein preparations using Xarrest agarose (Novagen).
GFP, 
 
D
 
N97 cyclin A–GFP, and GST-CAK were concentrated in 12.5 mM
Tris, pH 8.0, 200 mM NaCl, 2.5 mM DTT; 10 mM K
 
2
 
HPO
 
4
 
/KH
 
2
 
PO
 
4
 
, pH
7.2, 100 mM KCl; and 20 mM Tris, pH 8.0, 150 mM NaCl, 1 mM DTT, re-
spectively. 
 
D
 
N97 cyclin A–GFP preparations consisted of 
 
z
 
30% 
 
D
 
N97 cy-
clin A–GFP protein and 70% chaperonin proteins. All other proteins were
 
.
 
90% pure on Coomassie-stained gels. Histone H1 kinase assays were per-
formed as described previously (Krude et al., 1997).
 
Immunofluorescence
 
HeLa cells were seeded onto metasilicate-coated coverslips, then fixed and
stained using paraformaldehyde/Triton as described (Pines, 1997). All anti-
bodies were diluted in 3% BSA/PBS, and washes were carried out with
0.2% Tween 20/PBS. Rabbit polyclonal anticyclin A antibodies (Pines and
Hunter, 1991), monoclonal anti–
 
b
 
-tubulin antibodies (Amersham Pharma-
cia Biotech), and polyclonal anti-Mad2 (Babco) antibodies were used at di-
lutions of 1:2,000, 1:200, and 1:200, respectively. Monoclonal anticentroso-
mal CTR453 serum (a gift of Dr. Michel Bornens, Institut Curie, Paris,
France) was used undiluted. Secondary antibodies (Jackson ImmunoRe-
search Laboratories) were diluted 1:200. Coverslips were mounted in 0.1%
1,4-phenylenediamine, 90% glycerol in PBS, pH 9.0, containing 50 nM
TOTO-3 iodide (Molecular Probes). Cells were analyzed by confocal laser
scanning microscopy. Z-series of images were projected using Lasersharp
software (Bio-Rad Laboratories) and exported to Adobe Photoshop
 
®
 
.
 
Microinjection and Time-Lapse Imaging and Analysis
 
Cells were analyzed by time-lapse DIC-fluorescence microscopy as de-
scribed previously (Clute and Pines, 1999; Furuno et al., 1999). For compar-
ative quantitative analyses, all parameters were fixed: a fluorescence expo-
sure time of 200 ms, a 40
 
3
 
 oil objective with a numerical aperture of 1.0,
and an image bin size of 4 were used. Images were saved in IPLab Spectrum
format as unsigned 16 data using a reference look up table with a preset lin-
ear pixel intensity scale. IPLab Spectrum was used to quantify the amount
of fluorescence as described previously (Clute and Pines, 1999; Furuno et
al., 1999). DIC images were used to determine mitotic phases. Images were
converted to PICT format and exported to Adobe Photoshop
 
®
 
.
 
Quantification of Cyclin A–GFP Protein Levels In Vivo
 
To determine the fluorescence per mole of GFP, glass needles of fixed diame-
ter were filled with serial dilutions of GFP protein containing 1 mg/ml BSA, 
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images were taken as described by Howell et al. (2000), and the fluorescence
and volume of needles were quantified using IPLab Spectrum software. To
quantify the amount of endogenous cyclin A in late G2 phase cells, HeLa cells
were synchronized in late G2 phase according to Tobey et al. (1990) and
known numbers of cells were immunoblotted against fixed amounts of cyclin
A–GFP standard. Bands were quantified using NIH Image v1.61 software.
 
Online Supplemental Material
 
The levels of cyclin A in late G2 phase cells were quantified as described
in Materials and Methods. Two separate late G2 phase cell populations,
each immunoblotted in duplicate, were used. To distinguish YFP from
CFP fluorescence, custom-designed filter sets (JP4; Chroma Technology)
were used. To ensure that there were no bleed-through effects, fluores-
cence images were taken of HeLa cells microinjected with cytomegalovi-
rus promotor-driven cDNA constructs encoding either cyclin A–CFP or
cyclin B1–YFP. Identical microscope and camera settings and an exposure
time of 250 ms were used for all images. To determine the effect of 1%
DMSO on the duration of mitosis phases, HeLa cells were synchronized
in late G2 phase and followed by time-lapse microscopy either in the pres-
ence or absence of 1% DMSO. These results are available at http://
www.jcb.org/cgi/content/full/153/1/121/DC1.
Figure 1. Cyclin A–GFP is an appropriate marker
for endogenous cyclin A. (A) Cyclin A and cyclin
A–GFP have similar subcellular localizations.
HeLa cells were synchronized in S phase or late
G2 phase, fixed, and stained with anticyclin A
antibodies, together with either anti-CTR453 an-
tibodies to visualize centrosomes or anti–b-tubulin
antibodies to visualize the mitotic spindle. DNA
was visualized using TOTO-3 iodide. Confocal
microscopy was used to compile a series of z-sec-
tions through cells. To analyze cyclin A–GFP lo-
calization, HeLa cells were microinjected in
the nucleus in S phase (0–4 h after release from
thymidine/aphidicolin block) or late G2 phase
(9–11 h after release from thymidine/aphidicolin
block) with cyclin A–GFP cDNA (0.1 mg/ml) or
protein (9 mg/ml). The localization of cyclin A–GFP
was assayed by time-lapse fluorescence and DIC
microscopy. Note that the fluorescence levels in
the metaphase cells have been enhanced relative
to cells at earlier stages. (B) Cyclin A and cyclin
A–GFP are degraded in mitosis. Examples of G2
phase and anaphase HeLa cells treated as in A
and stained for endogenous cyclin A (top) or ex-
pressing cyclin A–GFP (bottom). Bars, 10 mm. 
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Results
 
Cyclin A–GFP Is a Valid Marker for Endogenous 
Cyclin A
 
Although cyclin A was known to be degraded before cy-
clin B, the precise timing of cyclin A degradation was un-
clear. Therefore, we analyzed cyclin A degradation in real
time using cyclin A–GFP fusion proteins (the somatic
form of human cyclin A, sometimes called cyclin A2). We
have validated previously a cyclin B1–GFP fusion protein
to analyze the in vivo degradation of human cyclin B1
(Clute and Pines, 1999), but we carefully characterized the
cyclin A–GFP fusion protein to ensure that it was an ap-
propriate marker for endogenous cyclin A. 
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First, we determined that cyclin A–GFP bound and acti-
vated Cdk2 with similar efficiency to wild-type cyclin A; cy-
clin A–GFP stimulated the histone H1 kinase activity of
Cdk2 to 111% of the level achieved by an equivalent amount
of wild-type cyclin A. Monomeric Cdk2 had 
 
,
 
0.6% of the
activity of cyclin A/Cdk2. To analyze the subcellular localiza-
tion of cyclin A–GFP during the cell cycle, HeLa cells were
microinjected in S or G2 phase with cyclin A–GFP cDNA or
purified protein, and followed by time-lapse fluorescence
and DIC microscopy (Fig. 1 A). These images were com-
pared with cells stained with anticyclin A antibodies, to-
gether with anti-CTR453 centrosomal antibodies or anti–
 
b
 
-tubulin antibodies, and with a DNA stain (Fig. 1 A). Cy-
clin A–GFP mimicked the localization of endogenous cyclin
A at each stage of the cell cycle. During S and G2 phases, cy-
clin A and cyclin A–GFP were nuclear and excluded from
the nucleoli; both also stained the centrosomes from early
prophase onwards, in agreement with previous reports
(Pines and Hunter, 1991; Bailly et al., 1992; Pagano et al.,
1992; Girard et al., 1995). From prophase, cyclin A and cy-
clin A–GFP became excluded from the condensing chromo-
somes in the nucleus. In prometaphase and metaphase, en-
dogenous cyclin A and cyclin A–GFP were distributed
throughout the cell and concentrated at the mitotic spindle.
Finally, we analyzed the stability of cyclin A–GFP
through the cell cycle. Like endogenous human cyclin A
(Pines and Hunter, 1990), cyclin A–GFP was stable in S and
G2 phases (Furuno et al., 1999). During mitosis, cyclin
A–GFP fluorescence rapidly decreased (Fig. 1 B), consis-
tent with the degradation of endogenous cyclin A (Fig. 1 B).
This decrease in cyclin A–GFP levels during mitosis was
conferred by cyclin A rather than GFP, because GFP was
stable throughout mitosis (data not shown).
 
Cyclin A–GFP Is Degraded from Early Prometaphase
 
To determine when cyclin A–GFP proteolysis was initiated,
HeLa cells were microinjected with cyclin A–GFP protein
and followed at 3-min intervals by time-lapse fluorescence
Figure 2. Cyclin A is degraded from early prometaphase by a 26S proteasome-dependent pathway and is not inhibited by the spindle check-
point. (A) Cyclin A begins to be degraded in prometaphase. HeLa cells synchronized in late G2 phase were microinjected in the nucleus with
cyclin A–GFP protein (9 mg/ml), and followed by time-lapse fluorescence and DIC microscopy. Images (200-ms exposure) were taken at
3-min intervals. The total cell fluorescence minus background was quantified for each cell in successive images of a time series and plotted
over time. A graph of a single cell (j), representative of 42 cells analyzed, is shown. The start and finish of NEBD are marked and an arrow
shows the time at which fluorescence levels began to decrease. The stages of mitosis are indicated at the top of the figure. Because metaphase
is relatively short and variable in HeLa cells (9.9 6 9.6 min in uninjected cells, n 5 42) and images were only taken at 3-min intervals, in some
cells (including the cell shown here) metaphase was not observed. Another cell was similarly injected and analyzed, but was treated with the
26S proteasome inhibitor MG-132 (100 mM; Calbiochem) during prometaphase. This cell remained in prometaphase for the duration of the
experiment (data not shown). The graph shown (s) is representative of three cells analyzed. P, prophase; P/M, prometaphase; A, anaphase;
T, telophase; G1, G1 phase. (B) Cyclin A begins to be degraded just after NEBD in PtK1 cells. Prophase PtK1 cells were microinjected with
cyclin A–GFP protein (9 mg/ml) and analyzed as in A. A graph of a single cell, representative of nine cells analyzed, is shown. The initiation
and completion of NEBD are marked and an arrow shows the time at which fluorescence levels began to decrease. The white arrowhead
shows the localization of cyclin A–GFP between condensing chromosomes in prophase, and an asterisk indicates the original position of the
nucleolus. M, metaphase. (C) Cyclin A–GFP is still degraded in the presence of taxol. HeLa cells synchronized in late G2 phase were injected
with cyclin A–GFP protein and analyzed as above. Once in prometaphase, cells were treated with 10 mM taxol (Sigma-Aldrich). The degra-
dation profile of a single cell, representative of four cells analyzed, is shown. DIC and fluorescence images show that cyclin A–GFP was com-
pletely degraded and that the cell remained in prometaphase for the duration of the experiment. Bars, 10 mm. 
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and DIC microscopy. The total fluorescence, i.e., the amount
of cyclin A–GFP, in individual cells was quantified and plot-
ted over time. Cyclin A–GFP protein levels consistently be-
gan to fall just after the start of NEBD, reaching very low lev-
els by the time chromosomes aligned (Fig. 2 A). Equivalent
results were obtained when cells were injected with a cDNA
expression construct rather than purified protein (data not
shown). The rapid decrease in cyclin A–GFP levels required
26S proteasome-mediated degradation because it was blocked
by the proteasome inhibitor MG-132 (Fig. 2 A).
 
Table I. Degradation Rates of Cyclin A–GFP D-Box Mutants
 
Construct
Rate of degradation
(mean 
 
6
 
SD)
 
n min
 
2
 
1
 
Cyclin A–GFP 13 19,926 
 
6
 
 5,611
Cyclin B1 D-box–cyclin A-GFP 6 17,961 
 
6
 
 4,266
R47A cyclin A–GFP 3 19,316 
 
6
 
 5,495
 
D
 
D-box cyclin A–GFP 10 20,604 
 
6
 
 4,682
 
Degradation rates were calculated from the linear part of the graphs plotted for the
decrease in fluorescence.
Figure 3. Cyclin A–GFP degradation is D-box independent and
temporally regulated by Cdk binding. (A) Schematic diagram of
cyclin A–GFP constructs. The D-box and cyclin box of human cy-
clin A and GFP are indicated. In the cyclin B1 D-box construct,
the D-box of cyclin A has been replaced with that of cyclin B1. The
R47A and DD-box constructs do not contain a functional D-box.
MAAIL and 1–98 constructs are non-Cdk binding forms of cyclin
A–GFP. The DN97 protein begins with a methionine, followed by
amino acid 98 of cyclin A. (B–G) Degradation profiles of the cyclin
A–GFP constructs in A. HeLa cells synchronized in late G2
phase were microinjected with cytomegalovirus promotor-driven
cDNAs (0.1 mg/ml) and followed by time-lapse fluorescence and
DIC microscopy at 3 min intervals. The total cell fluorescence
minus background was quantified for each cell and plotted over
time. A representative graph, together with the total number of
cells analyzed, is shown for each construct. The stages of mitosis
are indicated at the top of each figure. In G the stages of mitosis
for the two different constructs are shown. For some cells, no ob-
vious metaphase was observed. NEBD initiation and completion
or chromosome segregation are marked. Arrows indicate the
times at which fluorescence levels began to decrease. 
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To determine more precisely when cyclin A–GFP deg-
radation began, data were collated for the time in relation
to NEBD at which cyclin A–GFP levels began to decrease.
(We injected cyclin A–GFP protein rather than cDNA to
avoid any possible lag in the decrease of cyclin A–GFP
levels due to mRNA translation.) NEBD observed by DIC
correlated with the redistribution of cyclin A–GFP be-
tween the cytoplasm and nucleus. Thus, we defined the
initiation of NEBD as the time when the amount of cyclin
A–GFP fluorescence in the cytoplasm increased and that
in the nucleus decreased (NEBD was considered complete
when cyclin A–GFP fluorescence was equally distributed
throughout the cell). This analysis showed that cyclin
A–GFP protein levels decreased 0–9 min (average 5.4 
 
6
 
3.2 min) after the initiation of NEBD (
 
n
 
 
 
5
 
 20) (metaphase
occurred 15–51 min after NEBD, average 26 
 
6
 
 9.5 min, in
uninjected HeLa cells [
 
n
 
 
 
5
 
 37]). Cyclin A–GFP levels
never decreased before NEBD began.
It had been reported that cyclin A degradation occurred
during anaphase in nontransformed mammalian cells and
thus was delayed compared with transformed cells (Girard
et al., 1995). Therefore, we compared the degradation of
cyclin A–GFP in HeLa cells to that in the nontransformed
cell line PtK
 
1
 
. The level of cyclin A–GFP fluorescence also
decreased from early prometaphase in PtK
 
1
 
 cells (Fig. 2 B)
in a very similar manner to HeLa cells.
In prometaphase, chromosomes stochastically attach to the
mitotic spindle and congress to the cell equator. During this
time, chromosomes that are not attached to both poles acti-
vate the spindle checkpoint, preventing both cyclin B1 and
securin from being degraded and thereby inhibit ana-
phase.  Given that cyclin A–GFP was degraded during pro-
metaphase and that human cyclin A is unstable in nocoda-
zole-treated cells (Pines and Hunter, 1990; Pagano et al.,
1992), we predicted that prolonged activation of the spindle
checkpoint with a spindle poison should not affect the kinet-
ics of cyclin A–GFP degradation. To test this, prometaphase
cells that were degrading cyclin A–GFP were treated with
taxol (Fig. 2 C). These cells remained in prometaphase for
 
.
 
2 h, long after chromosome alignment is usually achieved,
showing that the spindle checkpoint was fully active, but this
had no effect on cyclin A–GFP degradation.
 
Cyclin A–GFP Degradation Is D-Box Independent and 
Regulated by Cdk Binding
 
To analyze how cyclin A degradation was initiated in early
prometaphase, before the metaphase degradation of cyclin
B1, we attempted to change the timing of cyclin A destruc-
tion by replacing the D-box of cyclin A with that of cyclin
B1 (Fig. 3 A). However, this had no effect on cyclin
A–GFP degradation; the protein levels still decreased just
after NEBD (Fig. 3 B). Moreover, the rate of degradation
of cyclin B1-D-box–cyclin A-GFP was similar to that of
wild-type cyclin A–GFP (Table I).
To determine whether the D-box was necessary for the
prometaphase degradation of cyclin A, constructs were
made either with the R47A mutation that perturbs D-box
function (Glotzer et al., 1991) or completely lacking the
D-box (Fig. 3 A). Both these mutant proteins were de-
graded with the same timing and rate as wild-type cyclin
A–GFP (Fig. 3, C and D, and Table I). We were able to
stabilize cyclin A in vivo by removing the first 97 amino
 
acids of human cyclin A, including the D-box and the adja-
cent lysine-rich region (Fig. 3 E).
Cdk binding had been shown to be required for the deg-
radation of 
 
Xenopus
 
 cyclin A in vitro (Stewart et al.,
1994). To analyze whether this altered its degradation
properties in vivo, we made an R
 
®
 
A mutation in the
MRAIL motif of the cyclin box (MAAIL), or used just the
first 98 amino acids of cyclin A with, or without, the D-box
(Fig. 3 A). None of these mutants were able to bind to
Cdk2 (data not shown; Stewart et al., 1994), but all were
degraded in mitosis in vivo (Fig. 3, F and G). However,
this degradation was delayed because protein levels did
not fall until sister chromatid segregation. Thus, although
Cdk binding was not required for the degradation of cyclin
A–GFP, it did influence the timing of its destruction.
 
Overexpression of Cyclin A–GFP Delays Chromosome 
Alignment and Anaphase Onset
 
Time-lapse analyses indicated that cyclin A may need to
be degraded in prometaphase to enable chromosomes to
align. Uninjected HeLa cells took an average of 26 
 
6
 
 9.5
min from the beginning of prometaphase (completion
of NEBD) to the alignment of chromosomes at the
metaphase plate (
 
n
 
 
 
5
 
 37). However, increasing the
amount of cyclin A–GFP increased the time between
NEBD and stable chromosome alignment or anaphase (up
to 
 
.
 
500 min). During this delay, chromosomes would
sometimes appear to align at the cell equator, but would
always become misaligned again in subsequent images
(see below). To confirm the effect of cyclin A–GFP over-
expression on chromosome alignment, we examined this
in PtK
 
1
 
 cells. Consistent with Rieder et al
 
. 
 
(1994), we
found that uninjected PtK
 
1
 
 cells took an average of 27 
 
6
 
7.5 min from the start of prometaphase to chromosome
alignment (
 
n
 
 = 15). But this period was extended to as long
as 405 min in PtK
 
1
 
 cells microinjected with increasing
amounts of cyclin A–GFP. This mitotic delay induced by
overexpressing cyclin A was not due to premature mitosis,
because the delay still occurred in PtK
 
1
 
 cells that were in-
jected with cyclin A–GFP protein in prophase. Overex-
pressing cyclin A–GFP in either PtK
 
1
 
 or HeLa cells had no
effect on the duration of prophase, anaphase or telophase
(data not shown).
To ensure that the delay in chromosome alignment in-
duced by cyclin A–GFP was not a result of the GFP tag,
we overexpressed untagged cyclin A with GFP as an in-
jection marker. Overexpressing wild-type cyclin A also
caused a delay in stable chromosome alignment and
anaphase (Fig. 4 A), whereas GFP alone had no effect on
mitosis (data not shown).
Given that cyclin A was normally degraded during
prometaphase, the delay in chromosome alignment and
anaphase caused by increased amounts of cyclin A might
have been due to a delay in its removal. In agreement with
this, we found that there was a linear relationship between
the period of time from NEBD completion to chromosome
alignment and the amount of cyclin A–GFP protein present
in cells at NEBD (Fig. 4 B). Cells in which the time from
NEBD completion to chromosome alignment was 
 
.
 
50 min
had a statistically significant delay in chromosome align-
ment compared with uninjected cells (significance level 
 
5
 
99%). Using the line of best fit, the minimum amount of cy- 
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clin A–GFP required to cause a delay in chromosome align-
ment corresponded to a fluorescence of 10
 
6
 
, equivalent to
half the amount of endogenous cyclin A in a late G2 phase
cell, i.e., a 1.5-fold increase in the total amount of cyclin A.
Furthermore, data from those cells with a delay in chromo-
some alignment (
 
n
 
 
 
5 10) showed that cyclin A–GFP levels
consistently fell to a threshold level of (3.6 6 2.8) 3 105
(equivalent to z1/5 the amount of endogenous cyclin A in
late G2 phase) before chromosomes could align. This indi-
cated that the delay in chromosome alignment and ana-
phase could occur under physiological conditions.
Our results indicated that cyclin A, or another pro-
tein(s) with which it competed for the degradation ma-
chinery, had to be removed in prometaphase in order for
Figure 4. Cyclin A delays chromosome alignment and anaphase
in a concentration-dependent manner. (A) Overexpression of
wild-type cyclin A delays chromosome alignment. Late G2 phase
HeLa cells were microinjected with cyclin A and GFP expression
constructs. DIC images were taken at 3-min intervals. A cell in
which the period of time from NEBD completion to chromo-
some alignment was prolonged (117 min) compared with unin-
jected cells (26 6 9.5 min, n 5 37) is shown and is representative
of 5 out of 15 cells analyzed. The duration of each mitotic phase is
indicated. (B) Concentration dependence of the cyclin A–induced
delay. HeLa cells were microinjected in late G2 phase with cyclin
A–GFP protein and followed by time-lapse fluorescence and
DIC microscopy at 3 min intervals. Identical microscope and
camera settings were used in all experiments and the time from
the completion of NEBD to chromosome alignment was plotted
against the total cell fluorescence minus background at NEBD
(before cyclin A–GFP degradation) for each cell. For cells where
stable chromosome alignment was not observed, the duration
from NEBD to sister chromatid segregation was measured. The
average period from completion of NEBD to chromosome align-
ment in uninjected HeLa cells (26 6 9.5 min, n 5 37) is indicated
by a black square with error bars. Prometaphase was statistically
prolonged compared with uninjected cells (significance level 5
99%) in those cells with periods from NEBD completion to chro-
mosome alignment .50 min (indicated by a dashed line). The
amount of cyclin A–GFP is also given in units (x) equivalent to the amount of endogenous cyclin A in a late G2 cell (see Materials and
Methods). (C) Chromosome alignment is delayed by MG-132. HeLa cells were treated in prophase (time 0) with 100 mM MG-132 (Cal-
biochem) to inhibit 26S proteasome-mediated degradation, and DIC images were taken at 3 min intervals. 1 cell, representative of 10
cells analyzed, is shown. NEBD was complete within 7 min, but chromosomes remained misaligned 160 min later. DMSO alone had no
effect (data not shown). Bars, 10 mm.den Elzen and Pines Prometaphase Destruction of Cyclin A 129
chromosomes to align. To confirm this in cells with physio-
logical levels of cyclin A, we inhibited ubiquitin-mediated
degradation in prometaphase with MG-132 (Fig. 4 C).
This caused cells to arrest with a phenotype similar to that
of cells overexpressing cyclin A, i.e., individual chromo-
somes continuously moved to and from the cell equator
and stable chromosome alignment was never achieved.
Cyclin A-GFP–induced Mitotic Delay Does Not Act via 
the Spindle Checkpoint
One means to prevent the alignment of chromosomes at
the cell equator would be to perturb their bipolar attach-
ment to the mitotic spindle. This would also activate the
spindle checkpoint and prevent anaphase. To test whether
the cyclin A–induced delay in chromosome alignment and
anaphase correlated with activating the spindle check-
point, we stained cells for the checkpoint protein Mad2.
Mad2 localizes to kinetochores that are not attached to the
mitotic spindle (Chen et al., 1996; Li and Benezra, 1996)
and this is thought to correlate with an active checkpoint.
Cells were microinjected with cyclin A–GFP cDNA and
those that had not aligned their chromosomes 50 min after
the completion of NEBD were scored as having a cyclin
A-GFP–induced delay and were fixed and stained for
Mad2. Mad2 did not localize to the kinetochores in any
cells with a cyclin A-GFP–induced delay (Fig. 5 A).
To test further whether the spindle checkpoint was ac-
tive during the cyclin A–induced mitotic delay, we ana-
lyzed the degradation of cyclin B1, which is inhibited by
the spindle checkpoint. Human cyclin B1 tagged with YFP
and cyclin A tagged with CFP were coexpressed in late
G2 phase HeLa cells. Using custom-designed filter sets,
the fluorescence levels of cyclin A–CFP and cyclin B1–
YFP were followed independently in the same cell. This
showed that cyclin B1–YFP was degraded during the cyclin
A–CFP-induced mitotic delay (Fig. 5 B). As a further indi-
cation for whether the spindle checkpoint was required for
the cyclin A–induced delay, we introduced a dominant
negative form of Bub1 to inactivate the checkpoint. Bub1
is an essential component of the spindle checkpoint and a
dominant negative form of this protein prevents cells from
arresting in mitosis in response to nocodazole (Taylor and
McKeon, 1997). Cells expressing dominant negative Bub1
entered anaphase prematurely (Fig. 5 C), in agreement
with studies in which anti-Mad2 antibodies were used to
inactivate the checkpoint (Gorbsky et al., 1998). However,
dominant negative Bub1 did not abrogate the delay in
chromosome alignment and anaphase caused by overex-
pressing cyclin A (Fig. 5 C). Finally, we added taxol to ac-
tivate the spindle checkpoint in cells overexpressing cyclin
A and B1. Taxol stabilized cyclin B1 and not cyclin A, in
agreement with our previous results, but we found that cy-
clin B1 only became stable once cyclin A had fallen below
a threshold amount (Fig. 5 D). Before this point, cyclin B1
continued to be degraded even in the presence of taxol, in-
dicating that excess cyclin A may interfere with the spindle
checkpoint signal.
The Mitotic Delay Induced by Cyclin A May Not Be 
Due to Its Associated Cdk Activity
The delay in chromosome alignment and anaphase caused
by increased levels of cyclin A–GFP could have been due to
cyclin A–associated Cdk activity. Alternatively, it may have
resulted from competition between cyclin A and another
mitotic regulator for a limiting component of the degrada-
tion machinery. We attempted to distinguish between these
two possibilities using DN97 cyclin A–GFP which could not
be degraded in vivo (Fig. 3 E), but could still stimulate Cdk2
histone H1 kinase activity to levels equivalent to that of cy-
clin A–GFP (87% of wild-type cyclin A). If the delay
caused by cyclin A was due to its associated Cdk activity,
then expressing the nondegradable DN97 cyclin A–GFP at
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levels above the threshold amount (3.6 3 105) of cyclin
A–GFP required to prevent chromosome alignment should
result in an arrest before chromosome alignment. However,
this was not observed. Instead, cells aligned their chromo-
somes normally, but arrested in either anaphase or telo-
phase (Fig. 6). With high levels of DN97 cyclin A–GFP, cells
underwent anaphase A and often anaphase B. Sometimes a
cleavage furrow formed, but this usually retracted and chro-
mosomes cycled back and forth between the cell equator
and the spindle poles. With lower levels of DN97 cyclin
A–GFP, cells underwent a normal anaphase and cytokine-
sis, but arrested in telophase with condensed chromosomesden Elzen and Pines Prometaphase Destruction of Cyclin A 131
and no nuclear envelope. Some cells with very low levels of
DN97 cyclin A–GFP proceeded through most of mitosis
normally, but telophase was prolonged (data not shown).
Discussion
In this paper we have analyzed the degradation of the mi-
totic regulator cyclin A using a GFP fusion protein to-
gether with live cell imaging. Cyclin A–GFP is a valid live
cell marker for endogenous cyclin A because it stimulates
the histone H1 kinase activity of Cdk2, localizes correctly
during the cell cycle, is stable in S and G2 phases, and is
degraded in mitosis.
Early Prometaphase Degradation of Cyclin A: 
Implications for Its Mitotic Functions and
Degradation Pathway
We find that cyclin A–GFP levels begin to decrease in
HeLa cells in early prometaphase, 0–9 min after the initia-
tion of NEBD. The majority of cyclin A–GFP has disap-
peared by the time chromosomes align at metaphase, con-
sistent with immunofluorescence results for endogenous
cyclin A. Cyclin A–GFP degradation also begins in early
prometaphase in the nontransformed PtK1 cell line. This is
in contrast to findings from Girard et al. (1995) who used
immunofluorescence to show that cyclin A degradation is
delayed until anaphase in nontransformed cells. This con-
tradiction might arise from the analyses of different cell
lines, but is more likely to be because immunofluorescence
can only determine when cyclin A has disappeared, rather
than when degradation is initiated.
Because cyclin A is degraded from NEBD onwards, its
mitotic function has probably been completed before
NEBD, consistent with our observation that cyclin A be-
comes dispensable for mitosis z10 min before NEBD (Fu-
runo et al., 1999). The timing of cyclin A degradation in
early prometaphase has important implications for the
mechanism by which it is carried out. Cyclin A proteolysis
is after cyclin B1/Cdk1 has been activated and translo-
cated to the nucleus (Ookata et al., 1992; Furuno et al.,
1999; Hagting et al., 1999), concordant with the require-
ment in vitro for cyclin B1/Cdk1 activity to trigger cyclin A
degradation (Félix et al., 1990; Luca et al., 1991; Lorca et
al., 1992b). We never observed cyclin A degradation be-
fore NEBD in HeLa or PtK1 cells, indicating that NEBD
itself may be required for cyclin A degradation, perhaps
because components that are essential for proteolysis are
sequestered in the cytoplasm.
The degradation of cyclin A during prometaphase pre-
sents a problem if it is mediated by the APC. Geley et al.
(page 137) in this issue provide evidence that the APC is
involved in the destruction of cyclin A; injecting antibod-
Figure 5. The delay in chromosome alignment and
anaphase does not correlate with an active spindle
checkpoint. (A) Mad2 is not on kinetochores in
cells delayed by cyclin A–GFP. HeLa cells express-
ing cyclin A–GFP cDNA were followed by time-
lapse microscopy. Cells that had not aligned their
chromosomes .50 min after NEBD were scored as
having a cyclin A–GFP-induced delay, and were
fixed and stained with anti-Mad2 antibodies and
TOTO-3 iodide. DIC images were taken before fix-
ation. Fluorescence images were compiled from a
series of z sections through cells. 1 cell, representa-
tive of 11 cells analyzed, is shown. (B) Cyclin B1–
YFP is degraded in cells delayed by cyclin A–CFP.
HeLa cells synchronized in late G2 phase were coin-
jected with cyclin A–CFP and cyclin B1–YFP ex-
pression vectors. Cells were followed by time-lapse
microscopy at 3-min intervals using custom-
designed filter sets to discriminate CFP fluorescence
from YFP fluorescence. The total cell fluorescence
minus background was quantified independently for
cyclin A–CFP and cyclin B1–YFP and plotted over
time. Graphs from a cell with a cyclin A–CFP-
induced delay in chromosome alignment and anaphase onset, representative of seven delayed cells analyzed, are shown. Initiation and
completion of NEBD and chromosome segregation are marked. Chromosomes did not segregate until 187 min, 172 min after the comple-
tion of NEBD. Arrows indicate the time points at which cyclin A–CFP and cyclin B1–YFP fluorescence levels began to decrease (30 and
63 min, respectively). (C) Dominant negative Bub1 does not abrogate the cyclin A–induced delay. HeLa cells synchronized in late G2
phase were coinjected with cDNAs encoding dominant negative Bub1 and either GFP or cyclin A–GFP, and followed by time-lapse fluo-
rescence and DIC microscopy. NEBD completion to chromosome segregation took 36 6 8.9 min in uninjected cells (n 5 46), but signifi-
cantly less time (,13 min, significance level 5 99%) in cells expressing Bub1 DN and GFP at a fluorescence $106 (n 5 11). In five out of
nine cells coexpressing cyclin A–GFP and Bub1 DN at levels .106 (the level of cyclin A–GFP required to cause a delay in chromosome
alignment in Fig. 4 B), NEBD to chromosome segregation was significantly prolonged compared with uninjected cells (.59 min). (D)
Taxol does not stabilize cyclin B1 in cells with increased amounts of cyclin A. HeLa cells synchronized in late G2 phase were injected with
cyclin B1–YFP alone or coinjected with cyclin A–CFP and cyclin B1–YFP expression constructs and followed as in B. Cells expressing cy-
clin B1–YFP cDNA alone were treated with taxol after cyclin B1–YFP degradation had commenced. The graph shown is representative
of four such cells. Arrows indicate the timing of taxol addition and the stabilization of cyclin B1–YFP. Cells coexpressing cyclin A–CFP
and B1–YFP were treated with 10 mM taxol if they had not aligned their chromosomes within 50 min of NEBD. Graphs of a single cell,
representative of seven cells analyzed, are shown. The cell remained in prometaphase for the duration of the experiment. Bar, 5 mm.The Journal of Cell Biology, Volume 153, 2001 132
ies against Cdc27, a component of the APC, prevents
cyclin A degradation in vivo, and both APCCdc20 and
APCCdh1 will ubiquitylate cyclin A in vitro. Currently, it is
thought that the APC needs to bind Cdc20 to be active in
mitosis (for review see Morgan, 1999) and that Cdc20 is re-
quired for cyclin A degradation in Drosophila and Xeno-
pus extracts because mutations in the Cdc20 homologue,
fizzy, or anti-Fizzy antibodies, stabilize cyclin A (Dawson
et al., 1995; Sigrist et al., 1995; Lorca et al., 1998). Further-
more, Geley et al. (2001) in this issue have found that anti-
Cdc20 antibodies prevent cyclin A degradation in human
cells. However, in animal cells, evidence indicates that
during prometaphase the spindle checkpoint keeps Cdc20
inactive until all the chromosomes have attached to both
poles of the spindle (Li et al., 1997; Fang et al., 1998; Gorb-
sky et al., 1998; Dobles et al., 2000). Yet here we show that
cyclin A is degraded both in prometaphase and in the
presence of taxol, indicating that if APCCdc20 does degrade
cyclin A, it is not inhibited by the spindle checkpoint.
Moreover, eliminating the spindle checkpoint by introduc-
ing dominant negative Bub1 causes cyclin B1 to begin to
be degraded at the same time as cyclin A (Geley et al.,
2001, this issue). Perhaps there are different forms of
APCCdc20, some of which are not inhibited by the spindle
checkpoint and can recognize cyclin A, but not cyclin B1.
In this respect, it may be relevant that Cdc20 has been re-
ported to bind directly to the NH2 terminus of cyclin A
(Ohtoshi et al., 2000). Alternatively, Geley et al. (2001)
suggest that cyclin A may simply be a much better sub-
strate for APCCdc20, such that it can still be degraded when
the spindle checkpoint reduces the availability of active
Cdc20.
Cyclin A Degradation Is D-Box Independent, but 
Requires Cdk Binding for Its Correct Timing
The conservation through evolution of the relative timing
of cyclin A and B proteolysis indicates that delaying cyclin
A degradation until metaphase might have an adverse ef-
fect on mitosis. Indeed, Clb5, the budding yeast cyclin
most analogous in function to cyclin A, must be destroyed
to allow Clb2 to be degraded, possibly because Clb5 phos-
phorylates Cdh1 and keeps it inactive (Shirayama et al.,
1999). To determine whether the prometaphase destruc-
tion of cyclin A is essential for normal mitosis, we at-
tempted to alter its timing by mutating the cyclin A D-box.
To our surprise, the D-box is not required for cyclin A
degradation in human cells, in contrast to the D-box–
dependent proteolysis of Xenopus cyclin A1 in Xenopus
egg extract (Kobayashi et al., 1992). Possibly the mitotic
degradation of human somatic cyclin A differs from that
of the embryonic Xenopus cyclin A1 in meiosis and early
embryos. Alternatively, these contradictions may be due
to a difference between in vivo and in vitro systems.
We also find that cyclin A degradation does not require
Cdk binding, again in contrast to the behavior of cyclin A
in Xenopus egg extracts (Stewart et al., 1994; Geley et al.,
Figure 6. Nondegradable cyclin A–GFP does not prevent chromosome alignment, but arrests cells in anaphase or telophase. Late G2
phase HeLa cells were microinjected with a DN97 cyclin A–GFP expression vector and analyzed by time-lapse microscopy. Cells were
scored as arrested if they remained in the same phase of mitosis for .3 h. Images of cells arrested in anaphase (A) or telophase (B) are
shown. The DNA in cell B was stained by adding 1 mg/ml Hoechst 33342 (Sigma-Aldrich). Data are representative of 23 cells analyzed:
12 arrested in anaphase, 7 arrested in telophase and 4 cells with low levels of DN97 cyclin A–GFP did not arrest. Bars, 10 mm.den Elzen and Pines Prometaphase Destruction of Cyclin A 133
2001, this issue). However, an inability to bind its Cdk
does alter the timing of cyclin A degradation, delaying this
until anaphase. Cyclin A and Cdk2 may be recognized as a
complex by the prometaphase ubiquitination and/or deg-
radation machinery, or Cdk2 might induce conformational
changes in cyclin A required for its prometaphase destruc-
tion. The degradation of non-Cdk–binding cyclin A–GFP
in anaphase is D-box independent, indicating that it is dis-
tinct from that of cyclin B1 and securin in metaphase
(Clute and Pines, 1999; Hagting, A., N. den Elzen, and J.
Pines, manuscript in preparation).
Proteolysis Is Required for Chromosome Alignment
and Anaphase
Increasing the level of cyclin A in mitosis causes a delay in
chromosome alignment and the start of anaphase. During
this delay, the chromosomes are dynamic: individual chro-
mosomes move independently to and from the cell equa-
tor. In the delay caused by cyclin A, it is obvious that sister
chromatids have not segregated because misaligned chro-
mosomes return to the metaphase plate in both PtK1 and
HeLa cells. Eventually, cells segregate their chromosomes
synchronously in an apparently normal anaphase.
Our observations that the length of the delay is directly
related to the amount of cyclin A–GFP, and that before
chromosomes align the amount of cyclin A–GFP has to be
reduced below a threshold equivalent to 0.2 times the
amount of cyclin A in a G2 phase cell, indicate that the
level of cyclin A specifically affects chromosome align-
ment and anaphase. Moreover, chromosome alignment
can be prevented by inhibiting the 26S proteasome from
prophase onwards, providing further evidence that a pro-
tein or proteins must be degraded during prophase and/or
prometaphase for chromosome alignment and anaphase.
Consistent with this, a dominant negative form of UBC3
blocks chromosome congression in PtK1 cells (Bastians et
al., 1999), although this protein usually acts in conjunction
with the Skp1-Cullin-F-box (SCF) complex, not the APC.
We are currently investigating the mechanism by which
cyclin A delays chromosome alignment and anaphase. The
lag does not appear to result from cyclin A–associated Cdk
activity per se, because expressing the nondegradable
DN97 cyclin A–GFP construct does not arrest cells before
chromosome alignment (Fig. 6; Geley et al., 2001, in this is-
sue). Instead, these cells proceed normally until they arrest
in anaphase B or telophase. This is in contrast to the
metaphase delay reported for the overexpression of non-
degradable cyclin A in Drosophila (Sigrist et al., 1995).
However, in this study, anaphase and telophase cells could
also be observed, leading the authors to conclude that the
metaphase arrest is leaky. An alternative explanation con-
gruent with our results is that cells arrest in anaphase with
chromosomes that are highly dynamic and often appear at
the cell equator (Fig. 6 A). Moreover, Su and Jaklevic
(2001) have shown recently that Drosophila cells at the
gastrula stage delay in metaphase after DNA damage, and
this delay correlates with the stabilization of cyclin A. Fur-
thermore, mutant cells lacking cyclin A are unable to delay
in mitosis and enter anaphase with an increased number of
lagging chromosomes (Su and Jaklevic, 2001). Thus, there
are conditions when the ability of cyclin A to prevent
anaphase may be used as part of a checkpoint to safeguard
genomic integrity. In agreement with our results, Su and
Jaklevic (2001) also found that the length of the metaphase
delay depended on the gene dosage of cyclin A.
We favor the interpretation that the ability of cyclin
A–GFP to delay chromosome alignment and anaphase de-
pends on its ability to be degraded. Cyclin A–GFP might
compete for a limiting component of the degradation ma-
chinery and prevent the degradation of another protein(s)
whose removal is required for chromosome alignment and
anaphase. However, we cannot discount the alternative
possibility that the inability of DN97 cyclin A–GFP to de-
lay chromosome alignment and anaphase is due to its in-
ability to phosphorylate key substrates of cyclin A/CDK
involved in chromosome alignment and anaphase. The ob-
servation that Drosophila cells lacking cyclin A cannot de-
lay in metaphase in response to DNA damage (Su and
Jaklevic, 2001) may also indicate that cyclin A directly in-
hibits anaphase.
We think it is unlikely that increasing cyclin A levels de-
lays mitosis by activating the spindle checkpoint, because
none of the misaligned chromosomes in cyclin A–GFP-
delayed cells stained for Mad2. This is prima facie evidence
that the spindle checkpoint is not active and that all the
chromosomes should be attached to both poles of the spin-
dle (Chen et al., 1996; Li and Benezra, 1996; Waters et al.,
1998). Furthermore, cyclin B1–YFP, whose degradation is
prevented by the spindle checkpoint (Clute and Pines,
1999), is degraded during a cyclin A–induced mitotic delay.
Lastly, abrogating the spindle checkpoint altogether using
a dominant negative Bub1 construct does not eliminate the
cyclin A–induced delay. Thus, it is more likely that increas-
ing cyclin A levels induce a delay through proteins that are
involved in chromosome alignment and the initiation of
anaphase, but not the spindle checkpoint, such as motor
proteins implicated in chromosome congression.
Intringuingly, we find that adding taxol to cells that are
degrading cyclin B1 in the presence of excess cyclin A
does not immediately stop cyclin B1 proteolysis. Instead, it
appears that cyclin A has to fall below a threshold level
before cyclin B1 becomes stable. Thus, rather than activat-
ing the spindle checkpoint, cyclin A may perturb the spin-
dle checkpoint signal. In support of this, we have observed
that cells expressing high amounts of cyclin A sometimes
begin to degrade cyclin B1 just after NEBD, in a similar
manner to cells expressing dominant negative Bub1. If ex-
cess cyclin A does interfere with the spindle checkpoint,
then this may have the same root cause as the inability to
align chromosomes, i.e., cyclin A may affect the structure
and or function of the kinetochore.
Is Sister Chromatid Segregation Dependent on 
Chromosome Alignment?
It is important to determine the relationship between the
delay in chromosome alignment and the delay in anaphase
caused by cyclin A. Preventing chromosome alignment
might directly cause the delay in the initiation of anaphase.
Alternatively, cyclin A may prevent chromosome align-
ment and anaphase through separate pathways. In this re-
spect, our preliminary observations indicate that the de-
struction of cyclin B1–YFP and hSecurin-YFP, an in vivo
marker for securin (Hagting, A., N. den Elzen, and J.
Pines, manuscript in preparation), may be slower in cyclin
A–CFP expressing cells, and Geley et al. (page 137) in
this issue also find that overexpressing cyclin A can affectThe Journal of Cell Biology, Volume 153, 2001 134
the destruction of cyclin B1. Whatever the mechanism, it
has important implications for how anaphase is regulated.
Finally, our studies show that the cleavage furrow is cor-
rectly set up at the equator of the cell without the need for
a stable metaphase plate. Further studies will be needed to
determine the relationship between proteolysis, chromo-
some alignment, and the initiation of anaphase and cytoki-
nesis in animal cells.
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